|Bid||562.45 x 800|
|Ask||562.72 x 1100|
|Day's range||553.00 - 562.72|
|52-week range||441.00 - 686.62|
|Beta (5Y monthly)||0.21|
|PE ratio (TTM)||10.16|
|Earnings date||04 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||690.00|
Dr. Elizabeth Clayborne, Adjunct Assistant Professor of Emergency Medicine at the University of Maryland School of Medicine and Emergency Physician at UM Capital Region Medical Center, joins Yahoo Finance to discuss the latest in the coronavirus pandemic.
Regulatory and pipeline updates from bigwigs like Regeneron (REGN) and Biogen (BIIB) have been the biotech sector's few key highlights during the past week.
Is (REGN) Outperforming Other Medical Stocks This Year?